Receptor-Assisted Nanotherapeutics for Overcoming the Blood–Brain Barrier

Mhaske, Akshada, Singh, Kamalinder orcid iconORCID: 0000-0001-7325-0711, Shukla, Shalini, Ahirwar, Kailash and Shukla, Rahul (2024) Receptor-Assisted Nanotherapeutics for Overcoming the Blood–Brain Barrier. Molecular Neurobiology . ISSN 0893-7648

[thumbnail of VOR]
PDF (VOR) - Published Version
Available under License Creative Commons Attribution.


Official URL:


Blood–brain barrier (BBB) is a distinguishing checkpoint that segregates peripheral organs from neural compartment. It protects the central nervous system from harmful ambush of antigens and pathogens. Owing to such explicit selectivity, the BBB hinders passage of various neuroprotective drug molecules that escalates into poor attainability of neuroprotective agents towards the brain. However, few molecules can surpass the BBB and gain access in the brain parenchyma by exploiting surface transporters and receptors. For successful development of brain-targeted therapy, understanding of BBB transporters and receptors is crucial. This review focuses on the transporter and receptor–based mechanistic pathway that can be manoeuvred for better comprehension of reciprocity of receptors and nanotechnological vehicle delivery. Nanotechnology has emerged as one of the expedient noninvasive approaches for brain targeting via manipulating the hurdle of the BBB. Various nanovehicles are being reported for brain-targeted delivery such as nanoparticles, nanocrystals, nanoemulsion, nanolipid carriers, liposomes and other nanovesicles. Nanotechnology-aided brain targeting can be a strategic approach to circumvent the BBB without altering the inherent nature of the BBB.

Repository Staff Only: item control page